INS and type 2 diabetes mellitus: In our cohort of T2D subjects (characterized by short duration and few treated with insulin), we did not find an increased risk of fragility fractures,(43) and therefore our subjects may not have progressed along the diabetic bone spectrum to result in increased fracture risk, despite beginning to develop some subtle bone changes.